Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125868951 | 12586895 | 1 | I | 20160407 | 20160721 | 20160725 | 20160725 | EXP | FR-ROCHE-1799995 | ROCHE | 71.00 | YR | F | Y | 0.00000 | 20160725 | MD | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125868951 | 12586895 | 1 | PS | TAMIFLU | OSELTAMIVIR PHOSPHATE | 1 | Oral | 1 SINGLE ADMINISTRATION | 21087 | 75 | MG | CAPSULE | QD | ||||||
| 125868951 | 12586895 | 2 | SS | BACTRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Intravenous (not otherwise specified) | Y | 0 | 1.6 | G | BID | |||||||
| 125868951 | 12586895 | 3 | SS | CEFTRIAXONE. | CEFTRIAXONE | 1 | Intravenous (not otherwise specified) | 1 SINGLE ADMINISTRATION | 63239 | 1 | GBQ | QD | |||||||
| 125868951 | 12586895 | 4 | SS | COUMADINE | WARFARIN SODIUM | 1 | Oral | 0 | .75 | DF | QD | ||||||||
| 125868951 | 12586895 | 5 | SS | AUGMENTIN | AMOXICILLINCLAVULANATE POTASSIUM | 1 | Oral | 1 SINGLE ADMINISTRATION | 0 | 75 | MG | CAPSULE | QD | ||||||
| 125868951 | 12586895 | 6 | SS | CLARITHROMYCIN. | CLARITHROMYCIN | 1 | Intravenous (not otherwise specified) | 1 SINGLE ADMINISTRATION | 0 | 1 | G | QD | |||||||
| 125868951 | 12586895 | 7 | C | SPECIAFOLDINE | FOLIC ACID | 1 | Unknown | 1 TABLET MORNING AND EVENING | 0 | 5 | MG | TABLET | |||||||
| 125868951 | 12586895 | 8 | C | ASPEGIC | ASPIRIN DL-LYSINE | 1 | Unknown | AT NOON | 0 | 100 | MG | ||||||||
| 125868951 | 12586895 | 9 | C | SODIUM BICARBONATE. | SODIUM BICARBONATE | 1 | Unknown | 0 | |||||||||||
| 125868951 | 12586895 | 10 | C | APIDRA | INSULIN GLULISINE | 1 | 0 | ||||||||||||
| 125868951 | 12586895 | 11 | C | LANTUS | INSULIN GLARGINE | 1 | 0 | ||||||||||||
| 125868951 | 12586895 | 12 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Unknown | 80MG IN THE MORNING, 40MG AT NOON | 0 | ||||||||||
| 125868951 | 12586895 | 13 | C | ESOMEPRAZOLE | ESOMEPRAZOLE | 1 | Unknown | 20MG IN THE MORNING | 0 | ||||||||||
| 125868951 | 12586895 | 14 | C | LEVOTHYROX | LEVOTHYROXINE | 1 | Unknown | IN THE MORNING | 0 | 100 | UG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125868951 | 12586895 | 1 | Pneumonia |
| 125868951 | 12586895 | 2 | Pneumonia |
| 125868951 | 12586895 | 3 | Pneumonia |
| 125868951 | 12586895 | 4 | Atrial flutter |
| 125868951 | 12586895 | 5 | Pneumonia |
| 125868951 | 12586895 | 6 | Pneumonia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125868951 | 12586895 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125868951 | 12586895 | International normalised ratio increased | |
| 125868951 | 12586895 | Rectal haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125868951 | 12586895 | 1 | 20160406 | 20160406 | 0 | |
| 125868951 | 12586895 | 2 | 20160407 | 20160407 | 0 | |
| 125868951 | 12586895 | 3 | 20160406 | 20160406 | 0 | |
| 125868951 | 12586895 | 4 | 20160405 | 0 | ||
| 125868951 | 12586895 | 5 | 20160406 | 20160406 | 0 | |
| 125868951 | 12586895 | 6 | 20160406 | 20160406 | 0 |